Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2008

View Archived Issues

Daiichi Sankyo updates recent activity

AVI initiates next-generation drug eluting stent trial with Global Therapeutics

Novexel commences phase II for NXL-104/ceftazidime combination in UTIs

Quigley completes phase IIb study of QR-333 in diabetic peripheral neuropathy

Vical completes enrollment in phase II CMV vaccine trial

Phase IIa results with INCB-018424 in rheumatoid arthritis lead to phase IIb trials

Phase I data reported for autoimmune disorders candidate LX-2931

RAPID data show radiographic activity in nonresponders, sustained benefits in extension study

HIV protease inhibitor saquinavir kills ovarian cancer cells

ACH-702: new data on preclinical antibacterial activity, pharmacokinetics

Pfizer reports on sulopenem prodrug antibiotics

Seroquel approved in Europe for new indications in bipolar disorder

Sevikar approved in Germany for hypertension

Sanofi-aventis reports new post hoc results from ATHENA trial of Multaq in AF/AFL

Boehringer announces results from the PETRO-Ex study of Pradaxa for stroke in AF

Yissum and BioLineRx enter license agreement for antihormone BL-5040 in IBD

Swissmedic approves ceftobiprole for complicated skin and soft tissue infections

Nymox reports positive results in 59-week study of NX-1207 for BPS

Novel antiobesity agents disclosed in recent patents

Recent Novartis patent discloses novel antiinflammatory agents

New diagnostic agents imparted by Merck Eprova

Antyra and Novo Nordisk sign licensing agreement for IGF antagonists

Ensemble and Roche extend collaboration for diagnostic technology in cancer therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...